|
| |
 |
 |
|
For the Years Ended March 31, 20102009, 2008, 2007 and 2006 |
| | |
| (Millions of Yen) |
| |
2010 |
2009 |
2008 |
2007 |
2006 |
 |
Net cash provided
by operating activities |
49,845 |
19,690 |
41,648 |
36,738 |
31,860 |
Net cash used in
investing
activities |
(25,230) |
(39,031) |
(33,734) |
(35,122) |
(29,184) |
 |
| Free cash flow |
(1) |
| |
24,615 |
(19,341) |
7,914 |
1,616 |
2,676 |
|
Net cash used in
financing
activities |
(29,434) |
16,738 |
(4,008) |
(1,007) |
(3,113) |
|
Decrease in cash and
cash
equivalents |
(4,680) |
(5,524) |
4,246 |
555 |
351 |
Cash and cash equivalents
at
beginning of period |
16,239 |
19,530 |
14,812 |
14,289 |
13,836 |
|
Cash and cash equivalents at
end of period |
11,558 |
16,239 |
19,530 |
14,812 |
14,289 |
|
|
Note: Consolidated cash flows disclosed from fiscal 2000
| (1) |
Free cash flow = Net cash
provided by operating activities + Net cash used in
investing activities |
|
|
|
|
 Depreciation, Capital Expenditures, and Research and Development Expenses |
| (Millions of yen) |
| |
2010 |
2009 |
2008 |
2007 |
2006 |
|
| Depreciation |
28,183 |
28,683 |
27,238 |
22,165 |
20,491 |
|
| Capital expenditures |
17,471 |
43,340 |
27,292 |
40,638 |
29,067 |
|
| Research and development |
13,280 |
15,277 |
15,289 |
14,649 |
14,557 |
| |
|
Final |
